Skip to main content

Table 2 Demographic data and baseline characteristics of PMP participants and non-participants (n = 452 at visit 3 (6 months) and n = 327 at visit 5 (12 months), patient questionnaires)

From: Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program

  

Participation in PMP

  

Months 0-6

Months 7-12

 

Yes

No

Yes

No

Patients [n]

261

191

190

137

Age, mean/median [years]

38.2/38.0

39.2/40.0

38.1/37.5

40.0/41.0

Gender, female [%]

76.2

70.5

77.9

75.7

Number of relapses during 12 months prior to baseline [n]

1.2 (0.8)

1.2 (1.0)

1.2 (0.8)

1.2 (0.9)

Prior MS therapy [%]

No

32.6

31.1

34.7

29.4

 

Yes

67.4

68.9

65.3

70.6